APUS - Apimeds Pharmaceuticals US Inc.
1.88
0 0%
Share volume: 31,594
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.88
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2025 | 11-12-2025 | |
| Cash flow financing | 267.200 K | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | |
| Cash flow | 246.887 K | 0.000 | |
| Net income | -402.397 K | -1.781 M | |
| Depreciation | 0.000 | 1.489 K | |
| Changes in inventories | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -22.540 K | |
| Net Borrowings | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 22.540 K | |
| Cash Change | 246.887 K | -1.749 M |